Trials / Completed
CompletedNCT06619392
A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of HRS-2129 and the Food Effect on Pharmacokinetics Following Single Dose Administration in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics in healthy subjects, and to evaluate the food effect on pharmacokinetics of HRS-2129.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-2129 | HRS-2129 |
| DRUG | HRS-2129 Placebo | HRS-2129 Placebo |
Timeline
- Start date
- 2024-10-17
- Primary completion
- 2025-01-20
- Completion
- 2025-01-20
- First posted
- 2024-10-01
- Last updated
- 2025-03-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06619392. Inclusion in this directory is not an endorsement.